Cell genome stability is maintained by DNA damage response by integrally coordinating DNA repair activity, cell cycle checkpoint, γ‐H2AX signalling and apoptosis program,6, 7, 8 all of which may greatly affect the therapeutic effect and tumour response to irinotecan.9, 10. This evidence concerns the gene H2AX and neoplasm.